+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of tuberculosis resistant to 1st line drugs with rifampycin and ethambutol, twice a week, with an initial supplement of kanamycin



Treatment of tuberculosis resistant to 1st line drugs with rifampycin and ethambutol, twice a week, with an initial supplement of kanamycin



Revista Medica de Chile 99(12): 928-933




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 044864124

Download citation: RISBibTeXText

PMID: 5157620


Related references

Intermittent treatment of resistant pulmonary tuberculosis with ethambutol and rifampicin plus an initial 4 week supplement of kanamycin. Acta Tuberculosea et Pneumologica Belgica 62(4): 327-328, 1971

Association of 4,4'-Diisoamyloxythiocarbanilide and Pyrazinamide, and 4,4'-Diisoamyloxythiocarbanilide and Kanamycin in the Treatment of Pulmonary Tuberculosis Caused by Bacteria Resistant to the 1st Line Drugs. La Semana Medica 124: 549-554, 1964

Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs. Science Reports of the Research Institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku 14(1): 91-93, 1967

Long-term results with rifampicin together with ethambutol and-or other drugs in the treatment of tuberculosis with cultures resistant to the standard drugs. Respiration; International Review of Thoracic Diseases 28: Suppl:91-6, 1971

Studies on the kanamycin resistance in Mycobacterium tuberculosis. V. Sensitivity of kanamycin-resistant mutants to various antituberculous drugs and mutation frequency to various drug resistance in kanamycin-resistant mutants. Journal of Antibiotics 12: 323-327, 1959

Technology, study and use of antituberculous drugs - isoniazid, pyrazinamide, rifampycin and ethambutol. Kazanskii Meditsinskii Zhurnal 81(2): 144-145, March-April, 2000

Ethambutol in the treatment of chronic cavernous tuberculosis resistant to many antituberculous drugs. Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 36(3): 215-227, 1968

Studies on kanamycin. IV. Effect of kanamycin on experimental tuberculosis of guinea pigs infected with the strains resistant to various drugs. Japanese Jour Bact 13(2): 95-100, 1958

The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs. Kekkaku 41(1): 39-46, 1966

Chemotherapy regimens used in retreatment of pulmonary tuberculosis: combination of ethambutol, thioamides and capreomycin or rifampycin. Bulletin of the International Union Against Tuberculosis 41: 186-187, 1968

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. Journal of Clinical Microbiology 48(5): 1683-1689, 2010

Activity of the second line preparations ethambutol and rifampicin in experimental tuberculosis produced by mycobacterium tuberculosis highly resistant to tuberculostatics. Problemy Tuberkuleza: 60-64, 1973

Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics. Problemy Tuberkuleza 51(12): 60-64, 1973

Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China. Diagnostic Microbiology and Infectious Disease 89(2): 112-117, 2016

Treatment of pulmonary tuberculosis in patients resistant to major drugs with second line drugs. Hoja Tisiologica 24(1): 5-88, 1967